Saltar al contenido
PivotalWire 10 ago 2026

EmpresasLSTA

LSTA · LISATA THERAPEUTICS, INC.

preparados farmaceuticos · CIK 0000320017

Documentos
11
recogidos hasta hoy
Ultimo
6 ago 2026
Informe trimestral

Todavia no se publican los trimestres de caja ni la dilucion de esta empresa: hacen falta datos de sus informes que solo se recogen de las que se siguen de cerca. Lo que ves abajo son sus documentos tal y como los presento ante la SEC.

Documentos presentados ante la SEC

2026

  1. 10-QInforme trimestralEDGAR
    Duda sustancial sobre la continuidad de la empresa…availability of such additional funding, management has concluded that there is substantial doubt regarding the Company’s ability to continue as a going concern for a period of twelve months after the date these consolidated financial state…
    Programa de venta continua de acciones (ATM)…Equity Issuances At The Market Offering Agreement On June 4, 2021, the Company entered into an At The Market Offering Agreement (the “ATM Agreement”) with H.C. Wainwright & Co., LLC, as sales agent…
  2. 8-KHecho relevanteEDGAR
  3. SC TO-T/ASC TO-T/AEDGAR
  4. 8-KHecho relevanteEDGAR
  5. SC 14D9/ASC 14D9/AEDGAR
  6. 8-KHecho relevanteEDGAR
  7. SC 14D9/ASC 14D9/AEDGAR
  8. SC TO-T/ASC TO-T/AEDGAR
  9. SC 14D9/ASC 14D9/AEDGAR
  10. SC TO-T/ASC TO-T/AEDGAR
  11. SC 14D9/ASC 14D9/AEDGAR